Citizens JMP analyst Constantine Davides lowered the firm’s price target on Option Care Health (OPCH) to $36 from $38 and keeps an Outperform rating on the shares. Option Care’s Q3 revenue and gross ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results